CompletedEarly Phase 1NCT00863122

Concentration and Activity of Lapatinib in Vestibular Schwannomas

Studying Vestibular schwannoma

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Principal Investigator: Jaishri O Blakeley, MD
Johns Hopkins University
Intervention: lapatinib(drug)
Enrollment: 26 enrolled
Eligibility: 18 years · All sexes
Timeline: 2009 – 2014

Study locations (7)

House Reserach Institute, Los Angeles, California, United States
Johns Hopkins Hospital, Baltimore, Maryland, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Washington University Medical Center, St Louis, Missouri, United States
New York University Medical Center, New York, New York, United States
Weil Cornell Medical College, New York Presbyterian Hospital, New York, New York, United States
Ohio State University Medical Center, Columbus, Ohio, United States

Collaborators

The Children's Tumor Foundation · GlaxoSmithKline · New York University · Ohio State University · House Research Institute · Washington University School of Medicine · Weill Medical College of Cornell University · Massachusetts General Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00863122 on ClinicalTrials.gov

Other trials for Vestibular schwannoma

Additional recruiting or active studies for the same condition.

See all trials for Vestibular schwannoma →

← Back to all trials